Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Coverage Available Only If : You have a Type 2 diabetes diagnosis confirmed by your physician You meet your provinces specific medical criteria Youve tried first-line diabetes medications (like metformin) first You qualify for the provincial program (seniors 65+, youth on OHIP+, social assistance recipients, etc.) Why This Matters : The Canadian Drug Agency assessed Wegovys cost-effectiveness in July 2025 and recommended a price reduction before public coverage could be justified
Semaglutide is a prescription medication that has recently been FDA-approved for use as a weight loss aid
Adipose tissue macrophages in aging-associated adipose tissue function
Yes, semaglutide can cause allergic reactions in some individuals
In 2025, clinical trials increased by 46%, focusing on combination therapies and improved formulations
